Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frampton

Showing results (231-240 of 2,541) with videos related to

Pageof 255
Sort By:
The Lancet. Oncology|July 4, 2012
Raising a glass of red wine against cancer, or not?Adam E Frampton, Justin Stebbing
Journal of Bacteriology|October 1, 1975
Labeling the deoxyribonucleic acid of Anacystis nidulansL Restaino, E W Frampton
Drugs|March 14, 2018
OnabotulinumtoxinA: A Review in the Prevention of Chronic MigraineJames E Frampton, Stephen Silberstein
The New England Journal of Medicine|January 5, 2022
A New Combination Immunotherapy in Advanced MelanomaAdam E Frampton, Shivan Sivakumar
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 5, 2016
Modeling the prevention of colorectal cancer from the combined impact of host and behavioral risk factorsMatthew Frampton, Richard S Houlston
Drugs|April 22, 2018
Correction to: OnabotulinumtoxinA: A Review in the Prevention of Chronic MigraineJames E Frampton, Stephen Silberstein
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 15, 2010
Patient-reported outcomes in clinical trials of inhaled asthma medications: systematic review and research needsGeoff K Frampton, Jonathan Shepherd
Physical Review Letters|March 16, 2007
Turnaround in cyclic cosmologyLauris Baum, Paul H Frampton
Pharmacoeconomics|June 7, 1994
Ranitidine: a pharmacoeconomic evaluation of its use in acid-related disordersJ E Frampton, D McTavish
Drugs|April 1, 1994
Parnaparin. A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disordersJ E Frampton, D Faulds
Pageof 255

Showing results (231-240 of 2,541) with videos related to

Sort By:
Pageof 255
The Lancet. Oncology|July 4, 2012
Raising a glass of red wine against cancer, or not?Adam E Frampton, Justin Stebbing
Journal of Bacteriology|October 1, 1975
Labeling the deoxyribonucleic acid of Anacystis nidulansL Restaino, E W Frampton
Drugs|March 14, 2018
OnabotulinumtoxinA: A Review in the Prevention of Chronic MigraineJames E Frampton, Stephen Silberstein
The New England Journal of Medicine|January 5, 2022
A New Combination Immunotherapy in Advanced MelanomaAdam E Frampton, Shivan Sivakumar
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 5, 2016
Modeling the prevention of colorectal cancer from the combined impact of host and behavioral risk factorsMatthew Frampton, Richard S Houlston
Drugs|April 22, 2018
Correction to: OnabotulinumtoxinA: A Review in the Prevention of Chronic MigraineJames E Frampton, Stephen Silberstein
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 15, 2010
Patient-reported outcomes in clinical trials of inhaled asthma medications: systematic review and research needsGeoff K Frampton, Jonathan Shepherd
Physical Review Letters|March 16, 2007
Turnaround in cyclic cosmologyLauris Baum, Paul H Frampton
Pharmacoeconomics|June 7, 1994
Ranitidine: a pharmacoeconomic evaluation of its use in acid-related disordersJ E Frampton, D McTavish
Drugs|April 1, 1994
Parnaparin. A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disordersJ E Frampton, D Faulds
Pageof 255